Sun Pharma Advanced Research Co Ltd SPARC.NS
₹191.26 ₹3.30 (1.70%) 1D
Last Updated: Oct 05, 12:00 AM·NSE
Pricing for IN stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Sun Pharma Advanced Research Co Ltd Stock Halal?
Shariah Compliance Analysis of SPARC.NS Stock
India Health Care Small Cap Yes. As of October 2026, Sun Pharma Advanced Research Co Ltd (SPARC.NS) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Sun Pharma Advanced Research Co Ltd passes Musaffa's business and financial screening criteria.
Sun Pharma Advanced Research Co. Ltd. is a bio-pharmaceutical company, which engages in the research and development of pharmaceuticals. The company is headquartered in Mumbai, Maharashtra and currently employs 316 full-time employees. The company went IPO on 2007-07-18. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology programs include vodobatinib (SCO-088), a BCR-ABL targeting tyrosine kinase inhibitor for refractory chronic myelogenous leukemia, and an anti-MUC-1 antibody-drug conjugate (ADC) with the potential to treat multiple cancers. The Company’s other programs include Sezaby for the treatment of neonatal seizures, Vodobatinib for the treatment of neurodegenerative disorders (SCC-138), Vibozilimod for the treatment of autoimmune disorders (SCD-044), SCD-153 for the treatment of alopecia areata, SBO-154 for multiple cancer indications and SCO-155 for treatment of cancer. SBO-154 is an anti MUC1 ADC being developed for multiple tumor types expressing MUC1.
SPARC.NS Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Sun Pharma Advanced Research Co Ltd is classified as halal.
HALALSun Pharma Advanced Research Co Ltd (SPARC.NS) Chart
Fetching Price Chart...
Financial Metrics & Statements of Sun Pharma Advanced Research Co Ltd (SPARC.NS)
FAQ's for Sun Pharma Advanced Research Co Ltd (SPARC.NS)
- As of October 2026, Sun Pharma Advanced Research Co Ltd SPARC.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sun Pharma Advanced Research Co Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Sun Pharma Advanced Research Co Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Sun Pharma Advanced Research Co Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Sun Pharma Advanced Research Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Sun Pharma Advanced Research Co Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Sun Pharma Advanced Research Co Ltd (SPARC.NS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
